Bone Therapeutics | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
-
41.00
1,000
Cost of Goods Sold (COGS) incl. D&A
407.00
372.00
392.00
534.00
-
-
Gross Income
407.00
372.00
392.00
534.00
-
-
SG&A Expense
7,030.00
8,620.00
14,596.00
16,272.00
15,985.00
15,964
EBIT
7,437.00
8,992.00
14,988.00
12,799.00
16,466.00
15,544
Unusual Expense
14.00
361.00
2,463.00
60.00
66.00
37
Non Operating Income/Expense
3,393.00
3,672.00
3,798.00
15.00
4,160.00
18
Interest Expense
176.00
254.00
566.00
389.00
423.00
2,572
Pretax Income
4,084.00
5,809.00
14,024.00
13,090.00
12,598.00
14,027
Income Tax
-
-
60.00
60.00
178.00
131
Equity in Affiliates
18.00
1.00
1.00
9.00
7.00
16
Consolidated Net Income
4,066.00
5,808.00
14,085.00
13,021.00
12,769.00
14,142
Net Income
4,079.00
5,734.00
14,144.00
12,989.00
12,752.00
14,218
Net Income After Extraordinaries
4,079.00
5,734.00
14,144.00
12,989.00
12,752.00
14,218
Net Income Available to Common
4,079.00
5,734.00
14,144.00
12,989.00
12,752.00
14,218
EPS (Basic)
13.38
1.69
1.91
1.90
1.86
1.87
Basic Shares Outstanding
6,849.70
6,849.70
7,419.30
6,849.70
6,849.70
7,610.80
EPS (Diluted)
0.60
0.84
1.91
1.90
1.86
1.87
Diluted Shares Outstanding
6,849.70
6,849.70
7,419.30
6,849.70
6,849.70
7,610.80
EBITDA
7,030.00
8,620.00
14,596.00
12,265.00
15,944.00
14,964
Other Operating Expense
-
-
-
4,007.00
-
-
Non-Operating Interest Income
150.00
126.00
195.00
173.00
197.00
66
Minority Interest Expense
13.00
74.00
59.00
32.00
17.00
76
About Bone Therapeutics
View Profile
